Emerson Electric Co. (NYSE: EMR) is scheduled to release its fiscal fourth-quarter earnings after Tuesday's market close, with investors watching for signs of sustained growth in industrial automation and software.
As Mondelez International prepares to report its quarterly results, investors are watching for signs of sustained growth and margin recovery in a competitive packaged foods landscape.
Veralto Corp. is set to report fourth-quarter earnings after Tuesday's market close, with investors watching for signs of sustained growth in water analytics and treatment demand. The report comes amid mixed signals from the broader environmental services sector.
Modular housing manufacturer Champion Homes (SKY) reports quarterly results Tuesday, with analysts eyeing slowing revenue growth against a backdrop of mixed peer performance and recent stock underperformance.
As ATI prepares to release its fourth-quarter results, investors are weighing steady analyst expectations against a mixed performance history and a buoyant aerospace sector.
Lumen Technologies (NYSE: LUMN) is scheduled to release its quarterly earnings after market close on Tuesday, with Wall Street bracing for another expected revenue decline as the telecom infrastructure giant continues its multi-year restructuring.
Video game giant Take-Two Interactive (TTWO) is scheduled to release its fiscal fourth-quarter earnings after Tuesday's market close. Investors are watching closely for signs of resilience in the gaming sector after recent stock declines and mixed performances from tech peers.
The diversified solutions provider faces analyst expectations of a nearly 30% year-over-year revenue drop when it reports Tuesday afternoon, following a mixed track record against Wall Street estimates.
All eyes are on Clorox as it prepares to report fourth-quarter earnings Tuesday afternoon. Investors are looking for signs of sustained recovery after a challenging period marked by cyberattacks and supply chain pressures.
Hubbell Incorporated (HUBB) is set to report its fourth-quarter earnings before the bell on Tuesday. Investors are watching closely to see if the electrical products manufacturer can meet heightened revenue expectations and maintain its recent stock momentum in a competitive sector.
Archer-Daniels-Midland (ADM) is set to report Q4 earnings Tuesday morning. Analysts project a slight revenue dip, but investor sentiment remains cautiously optimistic as the agribusiness leader navigates a volatile global market.
As The Hanover Insurance Group prepares to report its fourth-quarter results, investors are watching to see if the property and casualty insurer can meet revenue expectations in a volatile market. With peers like Travelers and Progressive already posting solid numbers, the pressure is on.
As Merck prepares to release its fourth-quarter results, investors are watching to see if the pharmaceutical leader can maintain its track record of exceeding expectations amid a slowing growth outlook.
Chipotle Mexican Grill is set to report its latest quarterly results Tuesday afternoon, with investors watching closely for signs of resilience in consumer spending and operational execution against a backdrop of moderating sales growth.
A private gauge of China's manufacturing activity edged higher in January, defying expectations of a slowdown, as export-oriented firms outperformed. The reading contrasts with weaker official data, highlighting a two-speed industrial sector amid persistent domestic headwinds.
Benchmark Electronics (NYSE:BHE) is set to report Q4 earnings after Tuesday's market close, with analysts forecasting a return to revenue growth. The electronics manufacturing services provider enters the report on a strong note, having outperformed expectations last quarter.
Defense electronics specialist Mercury Systems (MRCY) is set to report quarterly results after Tuesday's close, with analysts projecting a revenue dip despite recent stock strength and positive industry tailwinds.
As Pfizer prepares to report its fourth-quarter results, investors are weighing the company's strategic pivot beyond its COVID-19 portfolio against a backdrop of expected revenue declines. The report may set the tone for the broader pharmaceutical sector.
As H&R Block prepares to report its fourth-quarter results, investors are weighing its consistent history of surpassing revenue estimates against a challenging discretionary spending environment and recent stock pressure.
As Ingredion prepares to release its fourth-quarter results, investors are weighing whether the company can stabilize after a disappointing prior quarter. The broader staples sector's recent strength offers a cautiously optimistic backdrop.
